홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Methanol → N-hydroxy-4-benzyloxycarbonyl-1-{4-[5-fluoro-1-(2-trimethylsilylethane-sulfonyl)-indol-3-yl]-piperidine-1-sulfonyl}piperazine-2-(RS)-carboxamide

HRID 843006
노트
인쇄 미리보기

반응식

HRID 843006 반응식
[CH2:1]([O:8][C:9]([N:11]1[CH2:16][CH2:15][N:14]([S:17]([N:20]2[CH2:25][CH2:24][CH:23]([C:26]3[C:34]4[C:29](=[CH:30][CH:31]=[C:32]([F:35])[CH:33]=4)[N:28]([S:36]([CH2:39][CH2:40][Si:41]([CH3:44])([CH3:43])[CH3:42])(=[O:38])=[O:37])[CH:27]=3)[CH2:22][CH2:21]2)(=[O:19])=[O:18])[CH:13]([C:45](O)=[O:46])[CH2:12]1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(Cl)(=O)C(Cl)=O.C[Si](C)(C)[NH:56][O:57][Si](C)(C)C.CO>C(Cl)Cl.CN(C=O)C>[OH:57][NH:56][C:45]([CH:13]1[CH2:12][N:11]([C:9]([O:8][CH2:1][C:2]2[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=2)=[O:10])[CH2:16][CH2:15][N:14]1[S:17]([N:20]1[CH2:21][CH2:22][CH:23]([C:26]2[C:34]3[C:29](=[CH:30][CH:31]=[C:32]([F:35])[CH:33]=3)[N:28]([S:36]([CH2:39][CH2:40][Si:41]([CH3:43])([CH3:44])[CH3:42])(=[O:37])=[O:38])[CH:27]=2)[CH2:24][CH2:25]1)(=[O:18])=[O:19])=[O:46]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 887MethanolHCID 65578Oxalyl chlorideHCID 898151,1,1-trimethyl-N-((trimethylsilyl)oxy)silylamineHCID 15486972HCID 15486972, 화합물

생성물 1

HCID 15486973N-hydroxy-4-benzyloxycarbonyl-1-{4-[5-fluoro-1-(2-trimethylsilylethane-sulfonyl)-indol-3-yl]-piperidine-1-sulfonyl}piperazine-2-(RS)-carboxamide수율 86.3%

시약·촉매·용매 2

HCID 6228Dimethylformamide촉매HCID 6344Dichloromethane용매

실험 절차

To a solution of 4-benzyloxycarbonyl-1-{4-[5-fluoro-1-(2-trimethylsilylethane-sulfonyl)indol-3-yl]piperidine-1-sulfonyl}piperazine-2-(RS)-carboxylic acid(288 mg, 0.40 mmol), [prepared as described in Step 6 above] in methylene chloride (5 ml) at 0° C. were added a few drops of DMF and oxalyl chloride (89 ml, 1.0 mmol). The reaction mixture was warmed to RT over 1 h, and stirring was continued for an additional 14 h. The reaction mixture was concentrated in vacuo, redissolved in methylene chloride (5 ml) and cooled to 0° C. N,O-bis-trimethylsilyl hydroxylamine (0.304 ml, 1.42 mmol) added, the reaction was warmed to RT, stirred for 3 h, and then recooled to 0° C. After adding methanol (3 ml), the mixture was stirred for an additional 30 min., and then concentrated in vacuo. The residue was partitioned between methylene chloride (50 ml) and aqueous 2.4 M HCl (10 ml), the organic layer was separated and washed with saturated aqueous sodium bicarbonate, dried over MgSO4, and concentrated in vacuo to afford N-hydroxy-4-benzyloxycarbonyl-1-{4-[5-fluoro-1-(2-trimethylsilylethanesulfonyl)-indol-3-yl]-piperidine-1-sulfonyl}piperazine-2-(RS)-carboxamide as a yellow foam (250 mg, 86%). The residue was used without further purification.

후처리

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. dissolutionredissolved in methylene chloride (5 ml)
  3. temperaturecooled to 0° C
  4. temperaturethe reaction was warmed to RT
  5. stirringstirred for 3 h
  6. customrecooled to 0° C
  7. stirringthe mixture was stirred for an additional 30 min.
  8. concentrationconcentrated in vacuo
  9. customThe residue was partitioned between methylene chloride (50 ml) and aqueous 2.4 M HCl (10 ml)
  10. customthe organic layer was separated
  11. washwashed with saturated aqueous sodium bicarbonate
  12. dry with materialdried over MgSO4
  13. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-966a878e995e47e38334966d1b242a90
출처 데이터셋
uspto-grants-2002_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06376506B1

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트